Colin James Thomas, MD

Daniel J Landsburg, Nancy Musoke, Caren Gentile, Taylor R Brooks, Sunita D Nasta, Stefan K Barta, Jordan S Carter, Elise A Chong, Jakub Svoboda, Stephen J Schuster, Colin J Thomas, Emily B Tomasulo, Michael R Cook, Jennifer J D Morrissette, Paolo F Caimi, Brian T Hill Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma , Leukemia: 2026

John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Daniel Reef, Alexander Micah Gorzewski, John Seng Wang, Geoffrey Shouse, Catherine Reinert, Andinet Teferra, Esteban Toro Velez, Ari Pelcovits, Thomas A Ollila, William Bennett Clark, Victor Yazbeck, Joseph E Maakaron, Manali Kamdar, Lindsey A Fitzgerald, Alexey V Danilov, Reem Karmali, Natalie S Grover, Stefan K Barta, Timothy J Voorhees, Andy I Chen, Mazyar Shadman, Sairah Ahmed, Narendranath Epperla Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study , Blood Advances: 2026

Colin J. Thomas, Ming Jung Koh, Omar Elghawy, et al. Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium , Leukemia & Lymphoma: 2026

Michael Schneider, Luca Paruzzo, Federico Stella, Julia Han Noll, Matthew Ho, Victor Babatunde, Bianca Ho, Pooja Devi, Elise A Chong, Stefan K Barta, Sunita D Nasta, Jakub Svoboda, Jordan Carter, Michael R Cook, Nasheed M Hossain, Colin J Thomas, Vrutti Patel, Vitor B de Souza, Mohannad H Alkhatib, Ziyu Li, Melody Tan, Peter Michener, Puneeth Guruprasad, Antonio Imparato, Alberto Carturan, Patrizia Porazzi, Joseph A Fraietta, Stephen J Schuster, Ivan Maillard, Marco Ruella, Daniel J Landsburg Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy , Nature Communications: 2026

Colin J Thomas, Caroline S Myers, Jina Chung, Daniel Landsburg, Sunita D Nasta, Jakub Svoboda, Elise A Chong, Stephen J Schuster, Jordan Carter, Michael Cook, Emily Tomasulo, Omar Elghawy, Michael LaRiviere, Harper Hubbeling, John P Plastaras, Alain H Rook, Jennifer Villasenor-Park, Marco Ruella, Ellen Kim, Stefan K Barta Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden , Blood Neoplasia, 3(3): 2026

John Sharp, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Lindsey Fitzgerald, Daniel Reef, Andinet Teferra, Timothy J Voorhees, Supriya Gupta, Natalie S Grover, Stefan K Barta, Mazyar Shadman, Narendranath Epperla Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma , Blood Cancer Journal, 16(1): 2026

Jonathan A. Baron, Monica Chelius, Gurbani Singh, Michael D. Schad, Melanie Berger, Emeline R. Chong, Colin J. Thomas, Jordan S. Carter, Michael R. Cook, Sunita D. Nasta, Daniel J. Landsburg, Stefan K. Barta, Jakub Svoboda, Stephen J. Schuster, Nikhil Yegya-Raman, Michael J. LaRiviere, John P. Plastaras, Elise A. Chong and Harper Hubbeling Safe Integration of Radiation Therapy with Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas , Clinical Lymphoma Myeloma and Leukemia: 2026

Victoria Anne Gill, Thomas A Ollila, Urmi Ghosh, Narendranath Epperla, Lindsey A Fitzgerald, Natalie S Grover, Deborah M Stephens, Colin J Thomas, Yun Kyoung Ryu Tiger, Alexandra Noveihed, Matthew J Cortese, Megan M Herr, James A Davis, Brian T Hess, Adam Kidwell, Nirav N Shah, Tamara K Moyo, Nicole Altomare, Jonathon B Cohen, Megan Melody, Adit Dharia, Vaishalee P Kenkre, Geoffrey Shouse, Jonathan Moreira, Shuo Ma, Jane N Winter, Leo I Gordon, Reem Karmali, Ari Pelcovits Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas , Blood Advances: 2026

Omar Elghawy, Austin G. Yang, Jonathan H. Sussman, Colin J. Thomas, Jordan S. Carter, Daniel J. Landsburg, Jakub Svoboda, Ellen Kim, Alain H. Rook, Jina Chung, Jennifer Villasenor-Park, John P. Plastaras, Michael LaRiviere, Harper Hubbeling, Monica Chelius, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Stefan K. Barta Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome , JAAD, 92(3): 2025,634-636.

Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta1, Elise A. Chong1, Stephen J. Schuster1, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta Clinical Impact of Next-Generation Sequencing of T-cell Lymphomas: A Single Institution Experience , Clinical Lymphoma, Myeloma and Leukemia, 25(7): 2025,505-511.e2.